CM_101



NAME OF DRUG : CM_101

ALSO KNOWN AS : CM_101

LABORATORY : ChemomAb

STATUS AND ADVANCEMENT

Type of drug : anti CCL24 monoclonal antibody

Clinical trials advancement : Recruiting Phase 1

Estimated time to market : 134 months.

LABORATORY ABSTRACT ON THE DRUG

NOT PROVIDED

RECENT NEWS ON CM_101

SOME PUBLICATIONS RELATED WITH CM_101

SOME NASHBIOTECHS POINTS OF VIEW RELATED WITH CM_101


WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016  - Contact and TERMS OF USE